Biomarkers predict brain tumor's response to therapy

A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news164982427.html">Biomarkers predict brain tumor's response to therapy</a></p> <p>A report in <i>Cancer Research</i>, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.</p>